Cargando…

Bioinformatic analysis of allergens

Detalles Bibliográficos
Autor principal:	Gendel, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354249/ http://dx.doi.org/10.1186/2045-7022-1-S1-S22

Ejemplares similares

Current state-of-the-art for allergen immunoassays
por: Ulberth, Franz
Publicado: (2011)

Mechanisms of immune-tolerance to allergens on the mucosal surfaces
por: Akdis, Cezmi
Publicado: (2011)

Challenges in assessing the potential allergenicity of biotechnology products
por: Goodman, Richard
Publicado: (2011)

Allergenicity assessment of GMOs by the European safety authority
por: Wal, Jean Michel
Publicado: (2011)

What makes an antigen a food allergen?
por: Mills, Clare
Publicado: (2011)

Introductory lecture: Biochemical properties of food allergens
por: Poulsen, Lars K
Publicado: (2011)

Assessment of risk from food allergens cross-contamination
por: Alldrick, Anton
Publicado: (2011)

Protein or no protein? Using PCR for detecting allergens in foods
por: Röder, Martin, et al.
Publicado: (2011)

Digestion models: predicting the allergenic risk of novel food proteins
por: Herman, Rod
Publicado: (2011)

Wheat and maize allergy: which allergens are involved and relationship with symptoms severity
por: Pastorello, Elide Anna, et al.
Publicado: (2011)

Food allergen protein families and their structural characteristics: new data from Europrevail
por: Hoffmann-Sommergruber, Karin
Publicado: (2011)

From start to finish: quantitative allergen risk assessment of foods containing peanut advisory labeling
por: Remington, Ben, et al.
Publicado: (2011)

A Brother's Grimm true story: the valiant little triple-quadrupole - 7 allergens in one blow
por: Popping, Bert
Publicado: (2011)

Comparative analysis of the vaginal microbiome in health and disease
por: White, Bryan A, et al.
Publicado: (2011)

Transgenic biotechnology in forestry: what a long strange trip it's been
por: Strauss, Steven H
Publicado: (2011)

Between a chicken and a grape: estimating the number of human genes
por: Pertea, Mihaela, et al.
Publicado: (2010)

Trials in rare diseases: the need to think differently
por: Billingham, Lucinda, et al.
Publicado: (2011)

Comparative genomic analysis of mouse and human mammary tumors
por: Perou, Charles M
Publicado: (2011)

Division of labor: multiple and specialized controls of vegetative growth and development in a poplar tree
por: Busov, Victor, et al.
Publicado: (2011)

Genomic selection in loblolly pine - from lab to field
por: Isik, Fikret, et al.
Publicado: (2011)

Survival analysis: coping with non proportional hazards in randomized trials
por: Royston, Patrick, et al.
Publicado: (2011)

Synthetic and sequencing-based approaches to high-throughput genetic analysis
por: Shendue, Jay
Publicado: (2010)

Structure function analysis of P. falciparum VAR2CSA
por: Dahlbäck, Madeleine, et al.
Publicado: (2010)

Statistical issues in the analysis of non-pharmacological therapy trials with clustering by care-provider or therapy group
por: Roberts, Chris
Publicado: (2011)

The Eucalyptus grandis Genome Project: Genome and transcriptome resources for comparative analysis of woody plant biology
por: Myburg, Alexander, et al.
Publicado: (2011)

Analysis of 2,440 human exomes highlights the evolution and functional impact of rare coding variation
por: Akey, Joshua
Publicado: (2011)

Biochemical and virological analysis of the preference for the K65R multi-resistance nucleoside mutation in subtype C viruses
por: Wainberg, Mark A, et al.
Publicado: (2009)

Post-entry events of efficient R5 vs. inefficient X4 HIV-1 replication in primary CD4(+)T lymphocytes, a transcriptome analysis
por: Mariani, Samanta A, et al.
Publicado: (2009)

Potential inflammatory consequences in HIV controllers
por: Hunt, Peter W, et al.
Publicado: (2010)

Personalized oncogenomics
por: Jones, Steven JM, et al.
Publicado: (2010)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hmdrcdj1882ol6bmv9281am74q